Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
Prestige Consumer Healthcare (NYSE:PBH) has announced it will release its fiscal 2025 fourth quarter and year-end earnings results on Thursday, May 8, 2025, before market opening. The company will host a conference call to discuss the results at 8:30 a.m. ET on the same day.
Investors can access the live Internet webcast through the Investor Relations page of prestigeconsumerhealthcare.com. Phone participation is available through pre-registration, with participants recommended to join 10 minutes before the event. A replay of the conference call will be accessible for approximately one week following the live call via the company's Investor Relations page.
Prestige Consumer Healthcare (NYSE:PBH) ha annunciato che rilascerà i risultati del suo quarto trimestre e dell'anno fiscale 2025 giovedì 8 maggio 2025, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica per discutere i risultati alle 8:30 a.m. ET dello stesso giorno.
Gli investitori possono accedere alla diretta della webcast attraverso la pagina delle Relazioni con gli Investitori di prestigeconsumerhealthcare.com. La partecipazione telefonica è disponibile previa registrazione, con i partecipanti che si consiglia di unirsi 10 minuti prima dell'evento. Una registrazione della conferenza telefonica sarà accessibile per circa una settimana dopo la chiamata dal vivo tramite la pagina delle Relazioni con gli Investitori dell'azienda.
Prestige Consumer Healthcare (NYSE:PBH) ha anunciado que publicará sus resultados del cuarto trimestre y del año fiscal 2025 el jueves 8 de mayo de 2025, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica para discutir los resultados a las 8:30 a.m. ET el mismo día.
Los inversores pueden acceder a la transmisión en vivo a través de la página de Relaciones con Inversores de prestigeconsumerhealthcare.com. La participación telefónica está disponible mediante preinscripción, recomendándose a los participantes unirse 10 minutos antes del evento. Una repetición de la conferencia telefónica estará accesible durante aproximadamente una semana después de la llamada en vivo a través de la página de Relaciones con Inversores de la compañía.
Prestige Consumer Healthcare (NYSE:PBH)는 2025 회계연도 4분기 및 연간 실적을 2025년 5월 8일 목요일, 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8시 30분 ET에 결과를 논의하기 위한 전화 회의를 개최할 예정입니다.
투자자들은 prestigeconsumerhealthcare.com의 투자자 관계 페이지를 통해 생중계 웹캐스트에 접근할 수 있습니다. 전화 참여는 사전 등록을 통해 가능하며, 참가자는 이벤트 10분 전에 접속하는 것이 권장됩니다. 생중계 후 약 일주일 동안 회사의 투자자 관계 페이지를 통해 전화 회의의 재생을 이용할 수 있습니다.
Prestige Consumer Healthcare (NYSE:PBH) a annoncé qu'elle publiera ses résultats du quatrième trimestre et de l'exercice fiscal 2025 le jeudi 8 mai 2025, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique pour discuter des résultats à 8h30 ET le même jour.
Les investisseurs peuvent accéder à la diffusion en direct via la page des Relations Investisseurs de prestigeconsumerhealthcare.com. La participation par téléphone est disponible sur préinscription, avec des recommandations pour que les participants se joignent 10 minutes avant l'événement. Un enregistrement de la conférence téléphonique sera accessible pendant environ une semaine après l'appel en direct via la page des Relations Investisseurs de l'entreprise.
Prestige Consumer Healthcare (NYSE:PBH) hat angekündigt, dass es seine Ergebnisse für das vierte Quartal und das Geschäftsjahr 2025 am Donnerstag, den 8. Mai 2025, vor Markteröffnung veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Investoren können über die Investor-Relations-Seite von prestigeconsumerhealthcare.com auf das Live-Internet-Webcast zugreifen. Die Teilnahme per Telefon ist nach vorheriger Registrierung möglich, wobei den Teilnehmern empfohlen wird, 10 Minuten vor der Veranstaltung beizutreten. Eine Wiederholung der Telefonkonferenz wird etwa eine Woche nach dem Live-Anruf über die Investor-Relations-Seite des Unternehmens zugänglich sein.
- None.
- None.
TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
